References

1. Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95. View
2. Rondeau P, Bourdon E (2011) The glycation of albumin: structural and functional impacts. Biochimie 93: 645-658. View
3. Roohk HV, Zaidi AR (2008) A review of glycated albumin as an intermediate glycation index for controlling diabetes. J Diabetes Sci Technol 2: 1114- 1121. View
4. Nagayama H, Inaba M, Okabe R, Emoto M, Ishimura E, et al. (2009) Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. Biomed Pharmacother 63: 236-240. View
5. Yoshiuchi K, Matsuhisa M, Katakami N, Nakatani Y, Sakamoto K, et al. (2008) Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 55: 503-507. View
6. Bry L, Chen PC, Sacks DB (2001) Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 47: 153-163. View
7. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, et al. (2007) Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 18: 896-903. View
8. Jeffcoate SL (2004) Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 21: 657-665. View
9. Morozov V, Kalinski M, Jaggers J, Goncharov N, Sakuta G (2014) Ischemiamodified albumin as a marker of myocardium and skeletal muscle damage. Int J Cardiovasc Res 3:1. View
10. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC (2004) Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21: 29-34. View
11. Halliwell B (1988) Albumin--an important extracellular antioxidant? Biochem Pharmacol 37: 569-571. View
12. Peters T J (1996) All about albumin - Biiochemistry, Genetics, and Medical ApplicationsSan Diego: Academic Press.
13. Shaklai N, Garlick RL, Bunn HF (1984) Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem 259: 3812-3817. View
14. Bourdon E, Loreau N, Blache D (1999) Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 13: 233-244. View
15. Brownlee M (1995) The pathological implications of protein glycation. Clin Invest Med 18: 275-281. View
16. Cohen MP (2003) Intervention strategies to prevent pathogenetic effects of glycated albumin. Arch Biochem Biophys 419: 25-30. View
17. Baraka-Vidot J, Guerin-Dubourg A, Bourdon E and Rondeau P (2012) Impaired drugsbinding capacities of in vitro and in vivo glycated albumin. Biochimie. 94: 1960-1967. View
18. Baraka-Vidot J, Guerin-Dubourg A, Dubois F, Payet B, Bourdon E, et al. (2013) New insights into deleterious impacts of in vivo glycation on albumin antioxidant activities. Biochim Biophys Acta 1830: 3532-3541. View
19. Guerin-Dubourg A, Catan A, Bourdon E, Rondeau P (2012) Structural modifications of human albumin in diabetes. Diabetes Metab 38: 171-178. View
20. Anguizola JA, Basiaga SB, Hage DS (2013) Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin. Curr Metabolomics 1: 239-250. View
21. Soltys BJ, Hsia JC (1977) Fatty acid enhancement of human serum albumin binding properties. A spin label study. J Biol Chem 252: 4043-4048. View
22. Boonstra R and Tinnikov A A (1998) Increased corticosteroid binding capacity of plasma albumin but not of corticosteroid-binding globulin caused by ACTH-induced changes in free fatty acid concentrations in snowshoe hares and rabbits. J Endocrinol 156: 205-212. View
23. Brodersen R, Andersen S, Vorum H, Nielsen SU, Pedersen AO (1990) Multiple fatty acid binding to albumin in human blood plasma. Eur J Biochem 189: 343-349. View
24. Guentert TW, Frey BM, Luedin E, Heinzl S, Brodersen R (1990) Increase of plasma nonesterified fatty acid concentration and decrease of albumin binding affinity after intravenous injection of glycocholate-lecithin mixed micelles. J Lab Clin Med 116: 66-75. View
25. Huang L, Harvie G, Feitelson JS, Gramatikoff K, Herold DA, et al. (2005) Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis. Proteomics 5: 3314-3328. View
26. Matejtschuk P, Dash CH, Gascoigne EW (2000) Production of human albumin solution: a continually developing colloid. Br J Anaesth 85: 887- 895. View
27. Travis J, Bowen J, Tewksbury D, Johnson D, Pannell R (1976) Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma. Biochem J 157: 301-306. View
28. Jovanović VB, Penezić-Romanjuk AZ, Pavićević ID, Aćimović JM, Mandić LM (2013) Improving the reliability of human serum albuminthiol group determination. Anal Biochem 439: 17-22. View
29. Belgacem O, Stübiger G, Allmaier G, Buchacher A, Pock K (2007) Isolation of esterified fatty acids bound to serum albumin purified from human plasma and characterised by MALDI mass spectrometry. Biologicals 35: 43-49. View
30. Snyder SL, Sobocinski PZ (1975) An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem 64: 284-288. View
31. Rondeau P, Navarra G, Cacciabaudo F, Leone M, Bourdon E, et al. (2010) Thermal aggregation of glycated bovine serum albumin. Biochim Biophys Acta 1804: 789-798. View
32. Ellman G L (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77. View
33. Chesne S, Rondeau P, Armenta S and Bourdon E (2006) Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells. Biochimie. 10: 1467-1477. View
34. Baraka-Vidot J, Navarra G, Leone M, Bourdon E, Militello V, et al. (2014) Deciphering metal-induced oxidative damages on glycated albumin structure and function. Biochim Biophys Acta 1840: 1712-1724. View
35. Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233: 346-357. View
36. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685. View
37. Prost M (1992) Process for the determination by means of free radicals of the antioxidant properties of a living organism or a potentially aggressive agent. In U.S. Patent 5,135,850ed.)eds.), USA.
38. Girodon F, Blache D, Monget AL, Lombart M, Brunet-Lecompte P, et al. (1997) Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters. J Am Coll Nutr 16: 357-365. View
39. Ou B, Hampsch-Woodill M, Prior RL (2001) Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem 49: 4619-4626. View
40. Huang D, Ou B, Hampsch-Woodill M, Flanagan JA, Prior RL (2002) Highthroughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format. J Agric Food Chem. 50: 4437-4444 View
41. Bi S, Yan L, Sun Y, Zhang H (2011) Investigation of ketoprofen binding to human serum albumin by spectral methods. Spectrochim Acta A Mol Biomol Spectrosc 78: 410-414. View
42. Kurono Y, Kushida I, Tanaka H, Ikeda K (1992) Esterase-like activity of human serum albumin. VIII. Reaction with amino acid p-nitrophenyl esters. Chem Pharm Bull (Tokyo) 40: 2169-2172. View
43. Ozeki Y, Kurono Y, Yotsuyanagi T, Ikeda K (1980) Effects of drug binding on the esterase activity of human serum albumin: inhibition modes and binding sites of anionic drugs. Chem Pharm Bull (Tokyo) 28: 535-540. View
44. Watanabe H, Tanase S, Nakajou K, Maruyama T, Kragh-Hansen U, et al. (2000) Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem J 349 Pt 3: 813-819. View
45. Koga M, Murai J, Saito H, Mukai M, Matsumoto S, et al. (2010) Glycated albumin levels are higher relative to glycated haemoglobin levels in gastrectomized subjects. Ann Clin Biochem 47: 39-43. View
46. Hashimoto K, Osugi T, Noguchi S, Morimoto Y, Wasada K, et al. (2008) A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care 33: 509-511. View
47. Talwalkar SS, Bon Homme M, Miller JJ, Elin RJ (2008) Ischemia modified albumin, a marker of acute ischemic events: a pilot study. Ann Clin Lab Sci 38: 132-137. View
48. Ma SG, Xu W, Wei CL, Wu XJ, Hong B, et al. (2011) Role of ischemiamodified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients. Clin Biochem 44: 1299-1303. View
49. Turedi S, Patan T, Gunduz A, Mentese A, Tekinbas C, et al. (2009) Ischemia-modified albumin in the diagnosis of pulmonary embolism: an experimental study. Am J Emerg Med 27: 635-640. View
50. Chen CY, Tsai WL, Lin PJ, Shiesh SC (2011) The value of serum ischemiamodified albumin for assessing liver function in patients with chronic liver disease. Clin Chem Lab Med 49: 1817-1821. View
51. Oettl K, Stauber RE (2007) Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 151: 580-590. View
52. Janatova J, Fuller JK, Hunter MJ (1968) The heterogeneity of bovine albumin with respect to sulfhydryl and dimer content. J Biol Chem 243: 3612-3622. View
53. Foster J F (1977) Albumin Structure, Function and Uses Oxford: Pergamon, 53-84.
54. Amirtharaj GJ, Natarajan SK, Mukhopadhya A, Zachariah UG, Hegde SK, et al. (2008) Fatty acids influence binding of cobalt to serum albumin in patients with fatty liver. Biochim Biophys Acta 1782: 349-354. View